Trial reportBMC neurology2026
Effects of lower limb exoskeleton robot-assisted rehabilitation on motor function, activities of daily living, and electromyography in hemiplegic stroke: a randomized controlled trial.
Trial report in BMC neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
backgroundPost-stroke lower limb dysfunction affects the quality of life. Previous studies have confirmed that lower limb exoskeleton robots can improve the walking ability of stroke patients. This study aims to explore the impact of the UGO220 exoskeleton rehabilitation robot on the motor function and daily living ability of chronic stroke patients and to observe changes in lower limb muscle activity by surface electromyography before and after treatment.
methodsSixty stroke patients with hemiplegia were randomly divided into a conventional (CT, n = 30) group or a robot (RT, n = 30) group. Patients in both groups received 60 min of routine physical therapy and occupational therapy. The robot group received 30 min of lower limb exoskeleton robot-assisted gait training per day, whereas the conventional group received 30 min of physical therapist-assisted gait training per day, six days a week, for three consecutive weeks. The primary outcome was evaluated by Fugl-Meyer assessment-lower extremities (FMA-LE), and the secondary outcomes included the modified Barthel index (MBI) score, Berg balance scale (BBS), and lower extremity muscle surface electromyography (sEMG) of the rectus femoris, biceps femoris, anterior tibialis and medial gastrocnemius muscles, including the integrated EMG (iEMG) and root-mean-square (RMS) values.
resultsThe robot group had significantly greater improvements in FMA-LE and MBI compared to the conventional group. The electromyography results indicated that in terms of the activation of the anterior tibial muscle, the robot group performed better than the traditional group.
conclusionsThe UGO220 exoskeleton robot training is superior to conventional training in improving Activities of daily living and lower limb motor function. Moreover, it can better promote the improvement of the ankle dorsiflexion function.
trial registrationClinicalTrials.gov (ChiCTR2500096316)(2025-01-21).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.